160 related articles for article (PubMed ID: 7878291)
1. Hypercalcemia associated with hematologic malignancies.
Grauer A
Recent Results Cancer Res; 1994; 137():114-21. PubMed ID: 7878291
[No Abstract] [Full Text] [Related]
2. [Clinical studies on hematological malignancies accompanied by hypercalcemia].
Takahasi T; Hirokawa M; Kudo K; Takatsu H; Yoshida K; Miura A
Rinsho Ketsueki; 1986 Nov; 27(11):2070-7. PubMed ID: 2881005
[No Abstract] [Full Text] [Related]
3. Mechanisms of bone lesions in multiple myeloma and lymphoma.
Roodman GD
Cancer; 1997 Oct; 80(8 Suppl):1557-63. PubMed ID: 9362422
[TBL] [Abstract][Full Text] [Related]
4. [Hypercalcemia and neoplasms: recent advances in pathogenesis].
Virgolini L; Gallizia C
Recenti Prog Med; 1990 Oct; 81(10):635-41. PubMed ID: 2291007
[TBL] [Abstract][Full Text] [Related]
5. [Steroid-sensitive hypercalcemia].
Boström H; Widström A
Nord Med; 1967 Jun; 77(24):753-60. PubMed ID: 6026287
[No Abstract] [Full Text] [Related]
6. Incidence and pathophysiology of hypercalcemia.
Mundy GR
Calcif Tissue Int; 1990; 46 Suppl():S3-10. PubMed ID: 2105829
[TBL] [Abstract][Full Text] [Related]
7. [Hypercalcemia in myeloma].
Abe M
Nihon Rinsho; 2007 Dec; 65(12):2245-9. PubMed ID: 18069268
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the secretion of an osteoclast stimulating factor in myeloma.
Mundy GR; Raisz LG; Cooper RA; Schechter GP; Salmon SE
N Engl J Med; 1974 Nov; 291(20):1041-6. PubMed ID: 4413338
[No Abstract] [Full Text] [Related]
9. Multiple myeloma/hypercalcemia.
Oyajobi BO
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S4. PubMed ID: 17634143
[TBL] [Abstract][Full Text] [Related]
10. Cytokines as mediators of hypercalcemia of malignancy.
Pfeilschifter J
Recent Results Cancer Res; 1994; 137():1-19. PubMed ID: 7878289
[No Abstract] [Full Text] [Related]
11. [Non-Hodgkin's lymphoma associated with hypercalcemia, multiple osteolytic lesions and diabetes insipidus].
Pereira J; Grebe G; Lira P
Rev Med Chil; 1984 Jul; 112(7):689-92. PubMed ID: 6515180
[No Abstract] [Full Text] [Related]
12. The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.
Mundy GR; Ibbotson KJ; D'Souza SM; Simpson EL; Jacobs JW; Martin TJ
N Engl J Med; 1984 Jun; 310(26):1718-27. PubMed ID: 6328302
[No Abstract] [Full Text] [Related]
13. Hypercalcemia and lytic bone lesions in a patient with B-cell non-Hodgkin's lymphoma.
Jacobs RH; Larson RA; LeBeau M; Kluskens LF; Vardiman JW; Rowley JD; Golomb HM
N Engl J Med; 1984 Jan; 310(4):263-4. PubMed ID: 6318111
[No Abstract] [Full Text] [Related]
14. Tumor necrosis factor-beta and hypercalcemia.
Ishibashi K; Kodama M; Hanada S; Arima T
Leuk Lymphoma; 1992 Aug; 7(5-6):409-17. PubMed ID: 1493442
[TBL] [Abstract][Full Text] [Related]
15. [Hypercalcemia and cancer].
Coninx P; Grandfils F; Colin J; Lachapelle F; Andrien JM; Pirenne Y
Rev Med Liege; 1974 May; 29(10):284-8. PubMed ID: 4365350
[No Abstract] [Full Text] [Related]
16. [Hypercalcemic crises of myelomatous origin. Treatment with dichloromethylene diphosphonate].
Conte N; Di Virgilio R; Roiter I
Presse Med; 1984 Nov; 13(42):2586. PubMed ID: 6239268
[No Abstract] [Full Text] [Related]
17. Hypercalcemia in malignant lymphoma and leukemia.
Canellos GP
Ann N Y Acad Sci; 1974; 230():240-6. PubMed ID: 4595945
[No Abstract] [Full Text] [Related]
18. [Hypercalcemia and neoplasms].
Rossetti A; Taliani U; Pioli G; Sansoni P
G Clin Med; 1987; 68(6-7):335-8, 340-5. PubMed ID: 2888700
[No Abstract] [Full Text] [Related]
19. Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma.
Tsujimura H; Nagamura F; Iseki T; Kanazawa S; Saisho H
Am J Hematol; 1998 Oct; 59(2):168-70. PubMed ID: 9766803
[TBL] [Abstract][Full Text] [Related]
20. Pleural effusions in hematologic malignancies.
Alexandrakis MG; Passam FH; Kyriakou DS; Bouros D
Chest; 2004 Apr; 125(4):1546-55. PubMed ID: 15078773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
